BlueCrest Capital Management’s Pensare Acquisition Corp. Unit WRLSU Stock Holding History

BlueCrest Capital Management’s Portfolio WRLSU Stock Details WRLSU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-323,175	Closed	-$3.41M	–	1458
2018 Q4	$3.41M	Buy	+323,175	New	+$3.41M	0.18%	92
2018 Q3	–	Sell	-352,200	Closed	-$3.73M	–	1913
2018 Q2	$3.73M	Buy	+352,200	New	+$3.68M	0.1%	203

Other funds holding WRLSU

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

VOAM

Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Scoggin Management New York $935M AUM 301.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlueCrest Capital Management's WRLSU Position: Q1 2019 in Review

BlueCrest Capital Management sold out of Pensare Acquisition Corp. Unit (WRLSU) in Q1 2019, closing a stake of 323,175 shares — an estimated $3.41M sold.

BlueCrest Capital Management first reported a position in WRLSU in Q2 2018 and held it in 2 quarters. The position peaked at $3.73M in Q2 2018. 6 funds tracked by Wall St. Rank hold WRLSU as of Q1 2019.

BlueCrest Capital Management reported no remaining Pensare Acquisition Corp. Unit position as of Q1 2019 after selling out during the quarter.
BlueCrest Capital Management sold 323,175 Pensare Acquisition Corp. Unit shares in Q1 2019, an estimated $3.41M.
BlueCrest Capital Management first reported a position in Pensare Acquisition Corp. Unit in Q2 2018 and held it in 2 quarters.
BlueCrest Capital Management's Pensare Acquisition Corp. Unit position peaked at $3.73M in Q2 2018.
6 funds tracked by Wall St. Rank held Pensare Acquisition Corp. Unit as of Q1 2019.

Based on BlueCrest Capital Management's 13F filing for Q1 2019, filed 15 May 2019.